ImmuCell Corporation Investor Presentation February 2024

ImmuCell Corporation presents its business overview, strategic opportunities, and financial performance as of February 2024. The presentation covers the company's product lines including First Defense and Re-Tain, manufacturing operations, and market positioning in animal health. Topics include production capacity expansion, regulatory approvals, and market demand for subclinical mastitis treatment solutions.